Annual CFI
-$864.00 K
-$638.00 K-282.30%
31 December 2023
Summary:
Cellectar Biosciences annual cash flow from investing activities is currently -$864.00 thousand, with the most recent change of -$638.00 thousand (-282.30%) on 31 December 2023. During the last 3 years, it has fallen by -$801.60 thousand (-1284.62%). CLRB annual CFI is now -146.65% below its all-time high of $1.85 million, reached on 31 December 2013.CLRB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
+$21.30 K+100.00%
30 September 2024
Summary:
Cellectar Biosciences quarterly cash flow from investing activities is currently $0.00, with the most recent change of +$21.30 thousand (+100.00%) on 30 September 2024. Over the past year, it has increased by +$597.30 thousand (+100.00%). CLRB quarterly CFI is now -100.00% below its all-time high of $1.84 million, reached on 30 September 2013.CLRB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$309.70 K
+$597.30 K+65.85%
30 September 2024
Summary:
Cellectar Biosciences TTM cash flow from investing activities is currently -$309.70 thousand, with the most recent change of +$597.30 thousand (+65.85%) on 30 September 2024. Over the past year, it has increased by +$405.50 thousand (+56.70%). CLRB TTM CFI is now -115.21% below its all-time high of $2.04 million, reached on 30 September 2007.CLRB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLRB Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -282.3% | +100.0% | +56.7% |
| 3 y3 years | -1284.6% | +100.0% | -971.6% |
| 5 y5 years | -161.8% | +100.0% | +21.1% |
CLRB Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1284.6% | at low | +100.0% | -971.6% | +65.8% | |
| 5 y | 5 years | -3426.5% | at low | +100.0% | -1164.1% | +65.8% | |
| alltime | all time | -146.7% | +58.8% | -100.0% | +100.0% | -115.2% | +85.2% |
Cellectar Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | -$309.70 K(-65.9%) |
| June 2024 | - | -$21.30 K(-1.4%) | -$907.00 K(+2.4%) |
| Mar 2024 | - | -$21.60 K(-91.9%) | -$885.70 K(+2.5%) |
| Dec 2023 | -$864.00 K(+282.3%) | -$266.80 K(-55.3%) | -$864.10 K(+20.8%) |
| Sept 2023 | - | -$597.30 K(<-9900.0%) | -$715.20 K(+472.2%) |
| June 2023 | - | $0.00(0.0%) | -$125.00 K(-36.2%) |
| Mar 2023 | - | $0.00(-100.0%) | -$196.00 K(-13.3%) |
| Dec 2022 | -$226.00 K(+59.8%) | -$117.90 K(+1560.6%) | -$226.10 K(-5.0%) |
| Sept 2022 | - | -$7100.00(-90.0%) | -$237.90 K(+1.3%) |
| June 2022 | - | -$71.00 K(+135.9%) | -$234.90 K(+37.0%) |
| Mar 2022 | - | -$30.10 K(-76.8%) | -$171.50 K(+21.3%) |
| Dec 2021 | -$141.40 K(+126.6%) | -$129.70 K(+3063.4%) | -$141.40 K(+389.3%) |
| Sept 2021 | - | -$4100.00(-46.1%) | -$28.90 K(+16.5%) |
| June 2021 | - | -$7600.00(<-9900.0%) | -$24.80 K(-52.1%) |
| Mar 2021 | - | $0.00(-100.0%) | -$51.80 K(-17.0%) |
| Dec 2020 | -$62.40 K(+154.7%) | -$17.20 K(<-9900.0%) | -$62.40 K(+22.6%) |
| Sept 2020 | - | $0.00(-100.0%) | -$50.90 K(-5.7%) |
| June 2020 | - | -$34.60 K(+226.4%) | -$54.00 K(+86.9%) |
| Mar 2020 | - | -$10.60 K(+86.0%) | -$28.90 K(+18.0%) |
| Dec 2019 | -$24.50 K(-92.6%) | -$5700.00(+83.9%) | -$24.50 K(-93.8%) |
| Sept 2019 | - | -$3100.00(-67.4%) | -$392.40 K(+14.0%) |
| June 2019 | - | -$9500.00(+53.2%) | -$344.30 K(+2.8%) |
| Mar 2019 | - | -$6200.00(-98.3%) | -$334.80 K(+1.5%) |
| Dec 2018 | -$330.00 K(-4.8%) | -$373.60 K(-930.2%) | -$330.00 K(-856.9%) |
| Sept 2018 | - | $45.00 K(>+9900.0%) | $43.60 K(-258.0%) |
| June 2018 | - | $0.00(-100.0%) | -$27.60 K(-90.2%) |
| Mar 2018 | - | -$1400.00(<-9900.0%) | -$281.80 K(-18.7%) |
| Dec 2017 | -$346.70 K(+379.5%) | $0.00(-100.0%) | -$346.70 K(-16.2%) |
| Sept 2017 | - | -$26.20 K(-89.7%) | -$413.70 K(+6.5%) |
| June 2017 | - | -$254.20 K(+283.4%) | -$388.60 K(+180.4%) |
| Mar 2017 | - | -$66.30 K(-1.0%) | -$138.60 K(+91.7%) |
| Dec 2016 | -$72.30 K(+23.6%) | -$67.00 K(+5990.9%) | -$72.30 K(+201.3%) |
| Sept 2016 | - | -$1100.00(-73.8%) | -$24.00 K(-17.2%) |
| June 2016 | - | -$4200.00(<-9900.0%) | -$29.00 K(-12.1%) |
| Mar 2016 | - | $0.00(-100.0%) | -$33.00 K(-43.6%) |
| Dec 2015 | -$58.50 K | -$18.70 K(+206.6%) | -$58.50 K(+12.5%) |
| Sept 2015 | - | -$6100.00(-25.6%) | -$52.00 K(+8.1%) |
| June 2015 | - | -$8200.00(-67.8%) | -$48.10 K(+20.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | -$25.50 K(+109.0%) | -$39.90 K(+34.8%) |
| Dec 2014 | -$29.60 K(-101.6%) | -$12.20 K(+454.5%) | -$29.60 K(-2.3%) |
| Sept 2014 | - | -$2200.00(<-9900.0%) | -$30.30 K(-101.7%) |
| June 2014 | - | $0.00(-100.0%) | $1.81 M(0.0%) |
| Mar 2014 | - | -$15.20 K(+17.8%) | $1.81 M(-2.4%) |
| Dec 2013 | $1.85 M(-188.3%) | -$12.90 K(-100.7%) | $1.85 M(-1047.9%) |
| Sept 2013 | - | $1.84 M(>+9900.0%) | -$195.40 K(-90.4%) |
| June 2013 | - | $0.00(-100.0%) | -$2.04 M(-0.7%) |
| Mar 2013 | - | $28.80 K(-101.4%) | -$2.05 M(-2.1%) |
| Dec 2012 | -$2.10 M(-263.0%) | -$2.06 M(>+9900.0%) | -$2.10 M(+4744.3%) |
| Sept 2012 | - | -$8000.00(-42.9%) | -$43.30 K(-65.2%) |
| June 2012 | - | -$14.00 K(-7.3%) | -$124.40 K(-109.8%) |
| Mar 2012 | - | -$15.10 K(+143.5%) | $1.27 M(-1.2%) |
| Dec 2011 | $1.29 M(<-9900.0%) | -$6200.00(-93.0%) | $1.29 M(-0.3%) |
| Sept 2011 | - | -$89.10 K(-106.4%) | $1.29 M(-6.5%) |
| June 2011 | - | $1.38 M(>+9900.0%) | $1.38 M(<-9900.0%) |
| Mar 2011 | - | $0.00(-100.0%) | -$1700.00(0.0%) |
| Dec 2010 | -$1700.00(-90.6%) | -$1700.00(<-9900.0%) | -$1700.00(<-9900.0%) |
| Sept 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2009 | -$18.00 K(-101.6%) | $0.00(0.0%) | -$18.00 K(-50.0%) |
| Sept 2009 | - | $0.00(-100.0%) | -$36.00 K(-23.1%) |
| June 2009 | - | -$18.00 K(0.0%) | -$46.80 K(-104.1%) |
| Dec 2008 | $1.14 M(+157.1%) | -$18.00 K(+66.7%) | $1.14 M(+885.8%) |
| Sept 2008 | - | -$10.80 K(-122.0%) | $115.20 K(-88.2%) |
| June 2008 | - | $49.20 K(-95.6%) | $975.90 K(-36.6%) |
| Mar 2008 | - | $1.12 M(-207.4%) | $1.54 M(+248.2%) |
| Dec 2007 | $441.70 K(-130.6%) | -$1.04 M(-222.2%) | $441.70 K(-78.3%) |
| Sept 2007 | - | $849.90 K(+39.0%) | $2.04 M(-343.8%) |
| June 2007 | - | $611.40 K(+3152.1%) | -$834.90 K(-42.3%) |
| Mar 2007 | - | $18.80 K(-96.6%) | -$1.45 M(+0.2%) |
| Dec 2006 | -$1.45 M(+473.2%) | $555.50 K(-127.5%) | -$1.45 M(-28.8%) |
| Sept 2006 | - | -$2.02 M(>+9900.0%) | -$2.03 M(+836.3%) |
| June 2006 | - | -$1900.00(-109.0%) | -$216.80 K(-6.1%) |
| Mar 2006 | - | $21.20 K(-173.9%) | -$231.00 K(-8.4%) |
| Dec 2005 | -$252.20 K | -$28.70 K(-86.2%) | -$252.20 K(+12.8%) |
| Sept 2005 | - | -$207.40 K(+1188.2%) | -$223.50 K(+1288.2%) |
| June 2005 | - | -$16.10 K(<-9900.0%) | -$16.10 K(<-9900.0%) |
| Mar 2005 | - | $0.00 | $0.00 |
FAQ
- What is Cellectar Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Cellectar Biosciences?
- What is Cellectar Biosciences annual CFI year-on-year change?
- What is Cellectar Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cellectar Biosciences?
- What is Cellectar Biosciences quarterly CFI year-on-year change?
- What is Cellectar Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cellectar Biosciences?
- What is Cellectar Biosciences TTM CFI year-on-year change?
What is Cellectar Biosciences annual cash flow from investing activities?
The current annual CFI of CLRB is -$864.00 K
What is the all time high annual CFI for Cellectar Biosciences?
Cellectar Biosciences all-time high annual cash flow from investing activities is $1.85 M
What is Cellectar Biosciences annual CFI year-on-year change?
Over the past year, CLRB annual cash flow from investing activities has changed by -$638.00 K (-282.30%)
What is Cellectar Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of CLRB is $0.00
What is the all time high quarterly CFI for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly cash flow from investing activities is $1.84 M
What is Cellectar Biosciences quarterly CFI year-on-year change?
Over the past year, CLRB quarterly cash flow from investing activities has changed by +$597.30 K (+100.00%)
What is Cellectar Biosciences TTM cash flow from investing activities?
The current TTM CFI of CLRB is -$309.70 K
What is the all time high TTM CFI for Cellectar Biosciences?
Cellectar Biosciences all-time high TTM cash flow from investing activities is $2.04 M
What is Cellectar Biosciences TTM CFI year-on-year change?
Over the past year, CLRB TTM cash flow from investing activities has changed by +$405.50 K (+56.70%)